Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study

Restricted access

Object. By pursuing a policy of very early aneurysm treatment in neurosurgical centers, in-hospital rebleeds can be virtually eliminated. Nonetheless, as many as 15% of patients with aneurysm rupture suffer ultraearly rebleeding with high mortality rates, and these individuals are beyond the reach of even the most ambitious protocol for diagnosis and referral. Only drugs given immediately after the diagnosis of subarachnoid hemorrhage (SAH) has been established at the local hospital level can, in theory, contribute to the minimization of such ultraearly rebleeding. The object of this randomized, prospective, multicenter study was to assess the efficacy of short-term antifibrinolytic treatment with tranexamic acid in preventing rebleeding.

Methods. Only patients suffering SAH verified on computerized tomography (CT) scans within 48 hours prior to the first hospital admission were included. A 1-g dose of tranexamic acid was given intravenously as soon as diagnosis of SAH had been verified in the local hospitals (before the patients were transported), followed by doses of 1 g every 6 hours until the aneurysm was occluded; this treatment did not exceed 72 hours. In this study, 254 patients received tranexamic acid and 251 patients were randomized as controls. Age, sex, Hunt and Hess and Fisher grade distributions, as well as aneurysm locations, were congruent between the groups. Outcome was assessed at 6 months post-SAH by using the Glasgow Outcome Scale (GOS). Vasospasm and delayed ischemic neurological deficits were classified according to clinical findings as well as by transcranial Doppler (TCD) studies. All events classified as rebleeding were verified on CT scans or during surgery.

Conclusions. More than 90% of patients reached the neurosurgical center within 12 hours of their first hospital admission after SAH; 70% of all aneurysms were clipped or coils were inserted within 24 hours of the first hospital admission. Given the protocol, only one rebleed occurred later than 24 hours after the first hospital admission. Despite this strong emphasis on early intervention, however, a cluster of 27 very early rebleeds still occurred in the control group within hours of randomization into the study, and 13 of these patients died. In the tranexamic acid group, six patients rebled and two died. A reduction in the rebleeding rate from 10.8 to 2.4% and an 80% reduction in the mortality rate from early rebleeding with tranexamic acid treatment can therefore be inferred. Favorable outcome according to the GOS increased from 70.5 to 74.8%. According to TCD measurements and clinical findings, there were no indications of increased risk of either ischemic clinical manifestations or vasospasm that could be linked to tranexamic acid treatment. Neurosurgical guidelines for aneurysm rupture should extend also into the preneurosurgical phase to guarantee protection from ultraearly rebleeds. Currently available antifibrinolytic drugs can provide such protection, and at low cost. The number of potentially saved lives exceeds those lost to vasospasm.

Article Information

Address reprint requests to: Jan Hillman, M.D., Ph.D., Neurosurgical Department, University Hospital, S-581 85 Linköping, Sweden. email: jan.hillman@lio.se.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Graph showing the timing of admission for SAH to the primary referring hospital.

  • View in gallery

    Graph showing the timing of transportation from the primary referring hospital to the neurosurgical centers.

  • View in gallery

    Graphs showing the number of patients at risk for rebleeding after the first hospital admission and the number of recurrent hemorrhages in the control and antifibrinolytic groups.

References

1.

Bailes JESpetzler RFHadley MNet al: Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 72:5595661990Bailes JE Spetzler RF Hadley MN et al: Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 72:559–566 1990

2.

Bonita RThomson S: Subarachnoid hemorrhage: epidemiology, diagnosis, management, and outcome. Stroke 16:5915941985Bonita R Thomson S: Subarachnoid hemorrhage: epidemiology diagnosis management and outcome. Stroke 16:591–594 1985

3.

Broderick JPBrott TGDuldner JEet al: Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25:1342471994Broderick JP Brott TG Duldner JE et al: Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25:1342–47 1994

4.

Camarata PJHeros RCLatchaw RE: “Brain attack”: the rationale for treating stroke as a medical emergency. Neurosurgery 34:1441581994Camarata PJ Heros RC Latchaw RE: “Brain attack”: the rationale for treating stroke as a medical emergency. Neurosurgery 34:144–158 1994

5.

Chyatte DFode NCSundt TM Jr: Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage. J Neurosurg 69:3263311988Chyatte D Fode NC Sundt TM Jr: Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage. J Neurosurg 69:326–331 1988

6.

Edner GRonne-Engström E: Can early admission reduce aneurysmal rebleeds? A prospective study on aneurysmal incidence, aneurysmal rebleeds, admission and treatment delays in a defined region. Br J Neurosurg 5:6016081991Edner G Ronne-Engström E: Can early admission reduce aneurysmal rebleeds? A prospective study on aneurysmal incidence aneurysmal rebleeds admission and treatment delays in a defined region. Br J Neurosurg 5:601–608 1991

7.

Ekelund ASäveland HRomner Bet al: Is transcranial Doppler sonography useful in detecting late cerebral ischemia after aneurysmal subarachnoid hemorrhage? Br J Neurosurg 10:19251996Ekelund A Säveland H Romner B et al: Is transcranial Doppler sonography useful in detecting late cerebral ischemia after aneurysmal subarachnoid hemorrhage? Br J Neurosurg 10:19–25 1996

8.

Fisher CMKistler JPDavis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:191980Fisher CM Kistler JP Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9 1980

9.

Fodstad HLiliequist BSchannong Met al: Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol 10:9151978Fodstad H Liliequist B Schannong M et al: Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol 10:9–15 1978

10.

Fogelholm RHernesniemi JVapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 24:164916541993Fogelholm R Hernesniemi J Vapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 24:1649–1654 1993

11.

Fridriksson SHillman JLandtblom AMet al: Education of referring doctors about sudden onset headache in subarachnoid hemorrhage. Acta Neurol Scand 103:2382422001Fridriksson S Hillman J Landtblom AM et al: Education of referring doctors about sudden onset headache in subarachnoid hemorrhage. Acta Neurol Scand 103:238–242 2001

12.

Fuiji YTakeuchi SSasaki Oet al: Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 84:35421996Fuiji Y Takeuchi S Sasaki O et al: Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 84:35–42 1996

13.

Girvin JP: The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Am Neurol Assoc 98:1501521973Girvin JP: The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Am Neurol Assoc 98:150–152 1973

14.

Grosset DGStraiton JMcDonald Iet al: Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg 78:1831871993Grosset DG Straiton J McDonald I et al: Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg 78:183–187 1993

15.

Gumprecht HWinkler RGertstner Wet al: Therapeutic management of grade IV aneurysm patients. Surg Neurol 47:54591997Gumprecht H Winkler R Gertstner W et al: Therapeutic management of grade IV aneurysm patients. Surg Neurol 47:54–59 1997

16.

Hadjivassiliou MTooth CLRomanowski CAet al: Aneurysmal SAH: cognitive outcome and structural damage after clipping or coiling. Neurology 56:167216772001Hadjivassiliou M Tooth CL Romanowski CA et al: Aneurysmal SAH: cognitive outcome and structural damage after clipping or coiling. Neurology 56:1672–1677 2001

17.

Hijdra ABraakman RVan Gijn Jet al: Aneurysmal subarachnoid hemorrhage. Complications and outcome in a hospital population. Stroke 18:106110671987Hijdra A Braakman R Van Gijn J et al: Aneurysmal subarachnoid hemorrhage. Complications and outcome in a hospital population. Stroke 18:1061–1067 1987

18.

Hillman Jvon Essen CLeszniewski Wet al: Significance of “ultra-early” rebleeding in subarachnoid hemorrhage. J Neurosurg 68:9019071988Hillman J von Essen C Leszniewski W et al: Significance of “ultra-early” rebleeding in subarachnoid hemorrhage. J Neurosurg 68:901–907 1988

19.

Hunt WEHess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14201968Hunt WE Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20 1968

20.

Inagawa T: Effect of ultra-early referral on management outcome in subarachnoid haemorrhage. Acta Neurochir 136:51611995Inagawa T: Effect of ultra-early referral on management outcome in subarachnoid haemorrhage. Acta Neurochir 136:51–61 1995

21.

Inagawa T: Ultra-early rebleeding within six hours after aneurysmal rupture. Surg Neurol 42:1301341994Inagawa T: Ultra-early rebleeding within six hours after aneurysmal rupture. Surg Neurol 42:130–134 1994

22.

Inagawa TKamiya KOgasawara Het al: Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol 28:93991987Inagawa T Kamiya K Ogasawara H et al: Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol 28:93–99 1987

23.

Inagawa TTokuda YOhbayashi Net al: Study of aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Stroke 26:7617661995Inagawa T Tokuda Y Ohbayashi N et al: Study of aneurysmal subarachnoid hemorrhage in Izumo City Japan. Stroke 26:761–766 1995

24.

Jakobsson KESäveland HHillman Jet al: Warning leak and management outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 85:9959991996Jakobsson KE Säveland H Hillman J et al: Warning leak and management outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 85:995–999 1996

25.

Jane JAKassell NFTorner JCet al: The natural history of aneurysms and arteriovenous malformations. J Neurosurg 62:3213231985Jane JA Kassell NF Torner JC et al: The natural history of aneurysms and arteriovenous malformations. J Neurosurg 62:321–323 1985

26.

Jennett BBond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:4804841975Jennett B Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484 1975

27.

Juvela S: Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32:3233261989Juvela S: Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32:323–326 1989

28.

Kägstrom EPalma L: Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage. Acta Neurol Scand 48:2572651972Kägstrom E Palma L: Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage. Acta Neurol Scand 48:257–265 1972

29.

Kassell NFTorner JC: Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13:4794811983Kassell NF Torner JC: Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13:479–481 1983

30.

Kassell NFTorner JCAdams HP Jr: Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 61:2252301984Kassell NF Torner JC Adams HP Jr: Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 61:225–230 1984

31.

Kiyohara YUeda KHasuo Yet al: Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke 20:115011551989Kiyohara Y Ueda K Hasuo Y et al: Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke 20:1150–1155 1989

32.

Leipzig TJRedelman KHorner TG: Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. J Neurosurg 86:2202251997Leipzig TJ Redelman K Horner TG: Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. J Neurosurg 86:220–225 1997

33.

Le Roux PDElliott PJNewell DWet al: Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 85:39491996Le Roux PD Elliott PJ Newell DW et al: Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 85:39–49 1996

34.

Linn FHRinkel GJAlgra Aet al: The notion of “warning leaks” in subarachnoid haemorrhage: are such patients in fact admitted with a rebleed? J Neurol Neurosurg Psychiatry 68:3323362000Linn FH Rinkel GJ Algra A et al: The notion of “warning leaks” in subarachnoid haemorrhage: are such patients in fact admitted with a rebleed? J Neurol Neurosurg Psychiatry 68:332–336 2000

35.

Ljunggren BBrandt LKågström Eet al: Results of early operation for ruptured aneurysms. J Neurosurg 54:4734791981Ljunggren B Brandt L Kågström E et al: Results of early operation for ruptured aneurysms. J Neurosurg 54:473–479 1981

36.

Ljunggren BSäveland HBrandt Let al: Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 62:5475511985Ljunggren B Säveland H Brandt L et al: Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 62:547–551 1985

37.

Maurice-Williams RSWadley JP: Delayed surgery for ruptured intracranial aneurysms: a reappraisal. Br J Neurosurg 11:1041091997Maurice-Williams RS Wadley JP: Delayed surgery for ruptured intracranial aneurysms: a reappraisal. Br J Neurosurg 11:104–109 1997

38.

Milhorat THKrautheim M: Results of early and delayed operations for ruptured intracranial aneurysms in two series of 100 consecutive patients. Surg Neurol 26:1231281986Milhorat TH Krautheim M: Results of early and delayed operations for ruptured intracranial aneurysms in two series of 100 consecutive patients. Surg Neurol 26:123–128 1986

39.

Morris KMShaw MDFoy PM: Ischaemic deterioration following aneurysmal subarachnoid haemorrhage: definition by clinical criteria. Br J Neurosurg 7:1491531993Morris KM Shaw MD Foy PM: Ischaemic deterioration following aneurysmal subarachnoid haemorrhage: definition by clinical criteria. Br J Neurosurg 7:149–153 1993

40.

Mullan SDawley J: Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28:21231968Mullan S Dawley J: Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28:21–23 1968

41.

Nakagawa THashi K: The incidence and treatment of asymptomatic, unruptured cerebral aneurysms. J Neurosurg 80:2172231994Nakagawa T Hashi K: The incidence and treatment of asymptomatic unruptured cerebral aneurysms. J Neurosurg 80:217–223 1994

42.

Ohkuma HTsurutani HSuzuki S: Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 32:117611802001Ohkuma H Tsurutani H Suzuki S: Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 32:1176–1180 2001

43.

O'Neill PWest CRChadwick DWet al: Recurrent aneurysmal subarachnoid hemorrhage: incidence, timing and effects. A reappraisal in a surgical series. Br J Neurosurg 2:43481988O'Neill P West CR Chadwick DW et al: Recurrent aneurysmal subarachnoid hemorrhage: incidence timing and effects. A reappraisal in a surgical series. Br J Neurosurg 2:43–48 1988

44.

Roos Y: Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology 54:77822000Roos Y: Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology 54:77–82 2000

45.

Roos YBBeenen LFGroen RJet al: Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry 63:4904931997Roos YB Beenen LF Groen RJ et al: Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry 63:490–493 1997

46.

Rosenörn JEskesen VSchmidt Ket al: The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg 67:3293321987Rosenörn J Eskesen V Schmidt K et al: The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg 67:329–332 1987

47.

Sarti CToumilehto JSalomaa Vet al: Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 22:8488531991Sarti C Toumilehto J Salomaa V et al: Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 22:848–853 1991

48.

Säveland HHillman JBrandt Let al: Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 76:7297341992Säveland H Hillman J Brandt L et al: Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 76:729–734 1992

49.

Säveland HSonesson BLjunggren Bet al: Outcome evaluation following subarachnoid hemorrhage. J Neurosurg 64:1911961986Säveland H Sonesson B Ljunggren B et al: Outcome evaluation following subarachnoid hemorrhage. J Neurosurg 64:191–196 1986

50.

Seiler RWReulen HJHuber Pet al: Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine and transcranial Doppler ultrasound. Neurosurgery 23:5986041988Seiler RW Reulen HJ Huber P et al: Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation intravenous nimodipine and transcranial Doppler ultrasound. Neurosurgery 23:598–604 1988

51.

Steiger HJFritschi JSeiler RW: Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir 127:21261994Steiger HJ Fritschi J Seiler RW: Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir 127:21–26 1994

52.

Stroobandt GLambert OMenard E: The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms. Acta Neurochir 140:1481601998Stroobandt G Lambert O Menard E: The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms. Acta Neurochir 140:148–160 1998

53.

Taneda M: The significance of early operation in the management of ruptured intracranial aneurysms—an analysis of 251 cases hospitalized within 24 hours after subarachnoid haemorrhage. Acta Neurochir 63:2012081982Taneda M: The significance of early operation in the management of ruptured intracranial aneurysms—an analysis of 251 cases hospitalized within 24 hours after subarachnoid haemorrhage. Acta Neurochir 63:201–208 1982

54.

Torner JCKassell NFWallace RBet al: Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study. Neurosurgery 9:5065131981Torner JC Kassell NF Wallace RB et al: Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study. Neurosurgery 9:506–513 1981

55.

Uski TKLilja ÅSäveland Het al: Cognitive functioning and cerebrospinal fluid concentrations of neuropeptides for patients in good neurological outcomes after aneurysmal subarachnoid hemorrhage. Neurosurgery 47:8128182000Uski TK Lilja Å Säveland H et al: Cognitive functioning and cerebrospinal fluid concentrations of neuropeptides for patients in good neurological outcomes after aneurysmal subarachnoid hemorrhage. Neurosurgery 47:812–818 2000

56.

Vermeulen MLindsay KWMurray GDet al: Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:4324371984Vermeulen M Lindsay KW Murray GD et al: Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:432–437 1984

57.

Vermeulen Mvan Gijn JHijdra Aet al: Causes of acute deterioration in patients with a ruptured intracranial aneurysm. A prospective study with serial CT scanning. J Neurosurg 60:9359391984Vermeulen M van Gijn J Hijdra A et al: Causes of acute deterioration in patients with a ruptured intracranial aneurysm. A prospective study with serial CT scanning. J Neurosurg 60:935–939 1984

58.

Whitfield PCMoss HO'Hare Det al: An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding. J Neurol Neurosurg Psychiatry 60:3013061996Whitfield PC Moss H O'Hare D et al: An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding. J Neurol Neurosurg Psychiatry 60:301–306 1996

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 255 255 100
Full Text Views 384 384 24
PDF Downloads 183 183 9
EPUB Downloads 0 0 0

PubMed

Google Scholar